IP Library Granted Patent US 8,580,856
Granted Patent B2
US 8,580,856 · App. 13/760,197 · Granted Nov 12, 2013

Acetaminophen/ibuprofen combinations and method for their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,856
App. No.
13/760,197
Granted
Nov 12, 2013
Kind
B2
Abstract

A pharmaceutical dosage form is provided comprising a non-steroidal anti-inflammatory agent and acetaminophen, and methods for their use. In one embodiment, the dosage form is comprised of ibuprofen and acetaminophen as the sole pharmaceutically effective agents, wherein the ibuprofen and acetaminophen are in a weight ratio of about 12 parts:about 88 parts.

Claims (11)

1. A method for mitigating and/or treating fever, comprising:

providing an oral dose to a person in need thereof, wherein the oral dose comprises:

a) a first analgesic agent selected from the group consisting of ibuprofen; one or more pharmaceutically acceptable isomers, metabolites, polymorphs, and/or salts thereof; and mixtures thereof; and

b) a second analgesic agent selected from the group consisting of acetaminophen, pharmaceutically acceptable isomers, metabolites, polymorphs, and/or salts thereof; and mixtures thereof;

wherein the weight ratio of the first analgesic agent to the second analgesic agent is about 1 part to about 7.5 parts; and

wherein the first analgesic agent and the second analgesic agent are the sole active ingredients in the dose.

2. An analgesic, antipyretic preparation comprising:

a) a first analgesic agent selected from the group consisting of ibuprofen; one or more pharmaceutically acceptable isomers, metabolites, polymorphs, and/or salts thereof; and mixtures thereof; and

b) a second analgesic agent selected from the group consisting of acetaminophen, pharmaceutically acceptable isomers, metabolites, polymorphs, and/or salts thereof; and mixtures thereof;

wherein the weight ratio of the first analgesic agent to the second analgesic agent is about 1 part to about 7.5 parts; and

wherein the first analgesic agent and the second analgesic agent are the sole active ingredients in the dose.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0372 →
CERTIFICATE OF CONVERSION Recorded Jan 19, 2023
From: JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 062438/0521 →
MERGER Recorded Jan 27, 2022
From: JOHNSON & JOHNSON CONSUMER INC.
To: CHENANGO ZERO LLC
Reel/Frame 059618/0521 →
MERGER Recorded Jan 27, 2022
From: CHENANGO ZERO LLC
To: CHENANGO TWO LLC
Reel/Frame 058888/0133 →
MERGER AND CHANGE OF NAME Recorded Jan 27, 2022
From: CHENANGO TWO LLC; CURRAHEE HOLDING COMPANY INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 058888/0210 →
MERGER AND CHANGE OF NAME Recorded Jul 2, 2015
From: MCNEIL-PPC, INC.; JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 036049/0254 →